Clinical and MR outcomes from a phase III trial (TEMSO) of oral teriflunamide in multiple sclerosis with relapses.

  • Egon Stenager (Other)

Activity: Talks and presentations › Talks and presentations in private or public companies

Description

Abstract: Neurol Sci 2011;S41.002

Miller A et al on behalf of the TEMSO investigators
Period14. Apr 2011
Event titleAnnual meeting of the American Academy of neurology
Event typeConference
LocationHawaii, United StatesShow on map